Payments processing company EML has won more time to respond to a new pleading in a shareholder class action over its alleged failure to disclose Ireland central bank’s concerns with its anti-money laundering compliance.
A child removal class action against the state of New South Wales has been given more time to clarify its pleadings after a judge raised concerns that parts of the “important case” were unclear.
Lawyers representing two class actions against the state of Queensland over alleged unlawful removals of Indigenous children have called on the state to produce unredacted files about the lead applicants.
Macquarie Capital has hit back at a class action over an alleged misleading prospectus for Nuix’s $1.8 billion IPO, saying it was entitled as underwriter to rely on the software company’s promises.
3M is now facing two class actions in Victoria, after being hit with a case on behalf of ADF members who claim they suffered hearing loss from using defective combat earplugs.
Legal fees will eat up more than half of a $3.5 million settlement reached in a class action over deaths at a NSW aged care facility during the COVID-19 pandemic.
Healthcare giant Johnson & Johnson is facing a new class action alleging it sold talcum powder that was contaminated with asbestos and caused reproductive system cancers in women.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.